SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 6/22/22 Kintara Therapeutics, Inc. 8-K:5,9 6/21/22 11:313K Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 51K 2: EX-3.1 Articles of Incorporation/Organization or Bylaws HTML 35K 6: R1 Document and Entity Information HTML 49K 9: XML IDEA XML File -- Filing Summary XML 12K 7: XML XBRL Instance -- ktra-20220621_htm XML 16K 8: EXCEL IDEA Workbook of Financial Reports XLSX 6K 3: EX-101.LAB XBRL Labels -- ktra-20220621_lab XML 56K 4: EX-101.PRE XBRL Presentations -- ktra-20220621_pre XML 36K 5: EX-101.SCH XBRL Schema -- ktra-20220621 XSD 11K 10: JSON XBRL Instance as JSON Data -- MetaLinks 12± 19K 11: ZIP XBRL Zipped Folder -- 0000950170-22-011967-xbrl Zip 16K
EX-3.1 |
Exhibit 3.1
Profit Corporation: Certificate of Amendment (PURSUANT TO NRS 78.380 & 78.385/78.390) Certificate to Accompany Restated Articles or Amended and Restated Articles (PURSUANT TO NRS 78.403) Officer's Statement (PURSUANT TO NRS 80.030) TYPE OR PRINT - USE DARK INK ONLY - DO NOT HIGHLIGHT |
|
1. Entity information: |
Name of entity as on file with the Nevada Secretary of State: Kintara Therapeutics, Inc. Entity or Nevada Business Identification Number (NVID): NV20091193377 |
2. Restated or Amended and Restated Articles: (Select one) (If amending and restating only, complete section 1,2 3, 5 and 6) |
Certificate to Accompany Restated Articles or Amended and Restated Articles Restated Articles - No amendments; articles are restated only and are signed by an officer of the corporation who has been authorized to execute the certificate by resolution of the board of directors adopted on: The certificate correctly sets forth the text of the articles or certificate as amended to the date of the certificate. Amended and Restated Articles |
|
* Restated or Amended and Restated Articles must be included with this filing type. |
3. Type of Amendment Filing Being Completed: (Select only one box) |
Certificate of Amendment to Articles of Incorporation (Pursuant to NRS 78.380 - Before Issuance of Stock) The undersigned declare that they constitute at least two-thirds of the following: (Check only one box) incorporators board of directors The undersigned affirmatively declare that to the date of this certificate, no stock of the corporation has been issued |
(If amending, complete section 1, 3, 5 and 6.) |
|
|
X Certificate of Amendment to Articles of Incorporation (Pursuant to NRS 78.385 and 78.390 - After Issuance of Stock) |
|
The vote by which the stockholders holding shares in the corporation entitling them to exercise at least a majority of the voting power, or such greater proportion of the voting power as may be required in the case of a vote by classes or series, or as may be required by the provisions of the articles of incorporation* have voted in favor of the amendment is: in excess of a majority |
|
Officer's Statement (foreign qualified entities only) - Name in home state, if using a modified name in Nevada:
Jurisdiction of formation: Changes to takes the following effect: The entity name has been amended. Dissolution The purpose of the entity has been amended. Merger The authorized shares have been amended. Conversion Other: (specify changes)
* Officer's Statement must be submitted with either a certified copy of or a certificate evidencing the filing of any document, amendatory or otherwise, relating to the original articles in the place of the corporations creation. |
Profit Corporation: Certificate of Amendment (PURSUANT TO NRS 78.380 & 78.385/78.390) Certificate to Accompany Restated Articles or Amended and Restated Articles (PURSUANT TO NRS 78.403) Officer's Statement (PURSUANT TO NRS 80.030) |
|
. Effective Date and Time: (Optional) |
Date: Time: (must not be later than 90 days after the certificate is filed) |
. Information Being Changed: (Domestic corporations only) |
Changes to takes the following effect: The entity name has been amended. The registered agent has been changed. (attach Certificate of Acceptance from new registered agent) The purpose of the entity has been amended. X The authorized shares have been amended. The directors, managers or general partners have been amended. IRS tax language has been added. Articles have been added. Articles have been deleted. Other. The articles have been amended as follows: (provide article numbers, if available) Article SECOND of the Articles of Incorporation of Kintara Therapeutics, Inc. has been amended and restated as set forth below and on Annex A. (attach additional page(s) if necessary) |
. Signature: Required) |
X /s/ Robert Hoffman President and Chief Executive Officer Signature of Officer or Authorized Signer Title
X /s/ Scott Praill Chief Financial Officer Signature of Officer or Authorized Signer Title
*If any proposed amendment would alter or change any preference or any relative or other right given to any class or series of outstanding shares, then the amendment must be approved by the vote, in addition to the affirmative vote otherwise required, of the holders of shares representing a majority of the voting power of each class or series affected by the amendment regardless to limitations or restrictions on the voting power thereof. |
Please include any required or optional information in space below: (attach additional page(s) if necessary) |
See attached. |
Annex A
KINTARA THERAPEUTICS, INC.
Certificate of Amendment to Articles of Incorporation (Pursuant to NRS 78.385 and 78.390 - After Issuance of Stock)
The vote by which the stockholders holding shares in the corporation entitling them to exercise at least a majority of the voting power, or such greater proportion of the voting power as may be required in the case of a vote by classes or series, or as may be required by the provisions of the articles of incorporation* have voted in favor of the amendment is: in excess of a majority.
Article SECOND of the Articles of Incorporation of Kintara Therapeutics, Inc. is amended in its entirety to read as follows:
NUMBER OF SHARES WITH PAR VALUE:
275,000,000 COMMON - $0.001 PAR VALUE
5,000,000 PREFERRED - $0.001 PAR VALUE
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 10/27/23 Kintara Therapeutics, Inc. S-1/A 12:1.2M Donnelley … Solutions/FA 10/24/23 Kintara Therapeutics, Inc. S-1/A 20:2.4M Donnelley … Solutions/FA 10/04/23 Kintara Therapeutics, Inc. S-1 13:1.1M Donnelley … Solutions/FA 9/18/23 Kintara Therapeutics, Inc. 10-K 6/30/23 75:12M Donnelley … Solutions/FA 9/27/22 Kintara Therapeutics, Inc. S-8 9/27/22 4:271K Donnelley … Solutions/FA 9/27/22 Kintara Therapeutics, Inc. 10-K 6/30/22 79:15M Donnelley … Solutions/FA 8/03/22 Kintara Therapeutics, Inc. 424B5 1:859K Donnelley … Solutions/FA |